The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

20 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
36
Quantitative structure-activity relationships of N2-phenylguanines as inhibitors of herpes simplex virus thymidine kinases.EBI
University of Massachusetts Medical School
17
Sensitivity of monkey B virus (Cercopithecine herpesvirus 1) to antiviral drugs: role of thymidine kinase in antiviral activities of substrate analogs and acyclonucleosides.EBI
Glsynthesis
28
Novel selective human mitochondrial kinase inhibitors: design, synthesis and enzymatic activity.EBI
University of Ferrara
18
Understanding the binding of 5-substituted 2'-deoxyuridine substrates to thymidine kinase of herpes simplex virus type-1.EBI
Katholieke Universiteit Leuven
13
N2-phenyldeoxyguanosine: a novel selective inhibitor of herpes simplex thymidine kinase.EBI
Istituto Di Genetica Biochimica Ed Evoluzionistica
13
Design, synthesis and enzymatic activity of highly selective human mitochondrial thymidine kinase inhibitors.EBI
University of Ferrara
4
Design, synthesis and biological evaluation of 2'-deoxy-2',2'-difluoro-5-halouridine phosphoramidate ProTides.EBI
Cardiff University
10
3'-(1,2,3-Triazol-1-yl)-3'-deoxythymidine analogs as substrates for human and Ureaplasma parvum thymidine kinase for structure-activity investigations.EBI
Swedish University Agricultural Sciences
19
3'-[4-Aryl-(1,2,3-triazol-1-yl)]-3'-deoxythymidine analogues as potent and selective inhibitors of human mitochondrial thymidine kinase.EBI
Ghent University
2
Deoxyribonucleoside kinases activate nucleoside antibiotics in severely pathogenic bacteria.EBI
University of Copenhagen
13
Synthesis and antiviral evaluation of 6-(alkyl-heteroaryl)furo[2,3-d]pyrimidin-2(3H)-one nucleosides and analogues with ethynyl, ethenyl, and ethyl spacers at C6 of the furopyrimidine core.EBI
Brigham Young University
2
Synthesis and biological evaluation of an 123I-labeled bicyclic nucleoside analogue (BCNA) as potential SPECT tracer for VZV-tk reporter gene imaging.EBI
Katholieke Universiteit Leuven
7
Synthesis and preliminary evaluation of 18F- or 11C-labeled bicyclic nucleoside analogues as potential probes for imaging varicella-zoster virus thymidine kinase gene expression using positron emission tomography.EBI
Ku Leuven
17
N1-substituted thymine derivatives as mitochondrial thymidine kinase (TK-2) inhibitors.EBI
Instituto De QuíMica MéDica (Csic)
32
Nucleoside analogues as highly potent and selective inhibitors of herpes simplex virus thymidine kinase.EBI
Roche Discovery Welwyn
18
Synthesis, properties, and pharmacokinetic studies of N2-phenylguanine derivatives as inhibitors of herpes simplex virus thymidine kinases.EBI
University of Massachusetts Medical School
4
2'-Fluorosugar analogues of the highly potent anti-varicella-zoster virus bicyclic nucleoside analogue (BCNA) Cf 1743.EBI
Cardiff University
54
Structure-antiviral activity relationship in the series of pyrimidine and purine N-[2-(2-phosphonomethoxy)ethyl] nucleotide analogues. 1. Derivatives substituted at the carbon atoms of the base.EBI
Academy of Sciences of The Czech Republic
30
Structure-activity relationships of N2-substituted guanines as inhibitors of HSV1 and HSV2 thymidine kinases.EBI
University of Massachusetts Medical School
6
Compound of 3-hydroxyl pyridine, preparation method thereof and pharmaceutical use thereofBDB
Shenyang Sunshine Pharmaceutical